Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Metagenomi, Inc. Common Stock
MGX ยท SEC Filings
website
113
Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developin...
Price
0.7217
Market Cap
27.2 M
Float
29.94 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about MGX
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Metagenomi, Inc. Common Stock
MGX ยท SEC Filings
29.94 M
Float
0.7217
Price
27.2 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 5, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025
News
TYPE
HEADLINE
FILED AT
Prospectus
TYPE
HEADLINE
FILED AT
424B4
OFFERING | Shares amount: 6,250,000 | Share price: $15.00 | Offering amount: $93,750,000.00
Feb 12, 2024
Registrations
TYPE
HEADLINE
FILED AT
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 5, 2026
S-3
Form S-3 - Registration statement under Securities Act of 1933
Mar 17, 2025
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 17, 2025
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 9, 2024
S-1/A
INITIAL REGISTRATION FOR OFFERING | Shares amount: 6,250,000 | Share price: $16.00 EFFECTIVE
Feb 7, 2024
8-A12B
Form 8-A12B - Registration of securities [Section 12(b)]
Feb 5, 2024
Proxies
TYPE
HEADLINE
FILED AT
Ownerships
TYPE
HEADLINE
FILED AT
4
Reid Laurence (Reporting)
Sep 11, 2026
SCHEDULE 13G
Thomas Brian C. (Filed by)
Sep 10, 2026
4
Wein Matthew (Reporting)
Sep 10, 2026
4
Irish Jian (Reporting)
Sep 10, 2026
4
Wapnick Pamela (Reporting)
Sep 10, 2026
4
Reid Laurence (Reporting)
Jun 11, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Mar 26, 2025
CORRESP
Form CORRESP - Correspondence
Mar 21, 2025
LETTER
Form UPLOAD - SEC-generated letter
Mar 21, 2025
EFFECT
Form EFFECT - Notice of Effectiveness
Feb 9, 2024
CORRESP
Form CORRESP - Correspondence
Feb 7, 2024
LETTER
Form UPLOAD - SEC-generated letter
Feb 6, 2024